Peptide Drugs advanced
Glargine U300 Pharmacokinetics
Pharmacokinetic characterization of concentrated glargine 300 U/mL showing delayed absorption and constant 24-hour coverage.
By Encyclopeptide Editorial | 1 min read
insulin pharmacokinetics basal-insulin
Glargine U300 Pharmacokinetics
Overview
Pharmacokinetic characterization of concentrated glargine 300 U/mL showing delayed absorption and constant 24-hour coverage.
Structure
| Property | Value |
|---|---|
| Name | Glargine U300 Pharmacokinetics |
Mechanism of Action
Smaller depot size leads to delayed and more uniform absorption compared to glargine U100.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | Glargine U300 Pharmacokinetics |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about Glargine U300 Pharmacokinetics with interactive quizzes on Wikipept.
Take a Quiz on Wikipept